Novavax’s COVID And Flu Vaccine Trial Paused By FDA Due To Serious Safety Concerns. Novavax Stocks Plunge On News.
The FDA had to step in and put a pause on Novavax’s new COVID and Flu Vaccine after test participants reported serious nerve damage during newer trials, and other concerns. Novavax stocks plunged 40% after news of the US Food and Drug Administration’s program halt became public.